Drug-drug Interaction Study of CTP-543 and Rifampin in Healthy Adult Subjects

Status:
Completed

Trial end date:
2021-07-02

Target enrollment:

Participant gender:

This is a Phase 1 open-label study of the effect of rifampin on the pharmacokinetics of CTP-543 in healthy subjects.

Phase 1

Concert Pharmaceuticals